Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BL-8040 + G-CSF for stem cell mobilization in multiple myeloma
NCT03246529Phase 3Active, not recruiting
- Sponsor
- BioLineRx Ltd.
- Start
- Mar 2018
- Primary completion
- Dec 2020
- Modality
- Peptides
- Countries
- 5
01
Overview
A Phase 3 trial of motixafortide, sponsored by BioLineRx Ltd.. Started Mar 2018; status: active, not recruiting.
02
Drugs
motixafortide
Beyond the preview
Go deeper on NCT03246529.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03246529.